Skip to main content

Metozolv ODT FDA Approval History

FDA Approved: Yes (Discontinued) (First approved September 4, 2009)
Brand name: Metozolv ODT
Generic name: metoclopramide
Dosage form: Orally Disintegrating Tablets
Company: Salix Pharmaceuticals, Inc.
Treatment for: GERD, Gastroparesis

Marketing Status: Discontinued

Metozolv ODT is a fast–dissolving formulation of metoclopramide for the short–term treatment of adults with gastroesophageal reflux and for the relief of symptoms associated with diabetic gastroparesis.

Development timeline for Metozolv ODT

DateArticle
Sep  8, 2009Approval Salix Receives FDA Marketing Approval for Metozolv ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Feb 27, 2009Salix Announces FDA Complete Response Letter for Metozolv ODT
Nov 18, 2008FDA Extends Metozolv ODT Review Date

See also

Metozolv ODT (metoclopramide) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer